Newborn Screening Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2022

According to Stratistics MRC, the Global Newborn Screening Market is accounted from $599.77 million in 2016 to reach $1395.65 million by 2023 with a CAGR of 12.7%. Increasing chromosomal abnormalities in infants, growing awareness in urbanized nations and rising panel of newborn infections are some of the key factors fueling the market growth. However, lack of specialized infrastructure and socio- economic barriers in emerging countries are hindering the growth of the market. Government initiatives and screening of aging disorder provides ample opportunities for the market growth.
Sample Copy of This Report: https://marketreportscenter.com/request-sample/571482
Newborn screening is the practice of testing all babies in their starting stage of life for certain disorders and situations that can delay their normal growth. This testing is necessary in each state and is normally performed before the baby leaves the hospital. The circumstances included in newborn screening can cause severe health problems starting in infancy or childhood. Early detection and treatment can help out to avoid intellectual and physical disabilities and life threatening illnesses.

By test type, Dried Blood Spot (DBS) testing is a simple method of collecting, shipping and storing blood samples. DBS sampling has been used for clinical and pre-clinical pharmacokinetic studies, taking advantage of smaller sampling needs and simplified sample collection and handling. DBS sampling has also been used for disease surveillance in emerging nations.

North America captured the largest market share owing to the increasing awareness and increasing prevalence of cardiovascular disorders. Asia-Pacific region is expected to grow at a faster rate during the forecast period due to rising fertility rates and newborn death rates in the region.

Some of the key players in Newborn Screening market include Perkinelmer, Inc., Natus Medical Incorporated, Agilent Technologies Inc., Covidien PLC, Trivitron Healthcare, AB Sciex LLC, Masimo Corporation, GE Healthcare, Waters Corporation, Bio-Rad Laboratories, Inc., Bio Tek Instruments, Inc., Cardinal Health, Inc., Medtronic Plc, Thermo Fisher Scientific, Inc., Zen Tech S.A. and Neogen Labs Pvt. Ltd.

Technologies Covered:
• Electrophoresis
• DNA-Based Assays
• Pulse Oximetry Screening Technology
• Tandem Mass Spectrometry (TMS)
• Immunoassays and Enzymatic Assays
• Hearing Screen Technology
Full report with Table of Content: https://marketreportscenter.com/reports/571482/newborn-screening-global-market-outlook-2017-2023
Product Types Covered:
• Reagents and Assay Kits
• Instruments

Test Types Covered:
• Hearing Screen Test
• Dry Blood Spot Test
• Critical Congenital Heart Diseases (CCHD) Test

End-Users Covered:
• Ambulatory Care
• Hospitals
• Nursing Homes

Diseases Covered:
• Hearing Disability
• Blood Spot Disease
• Thyroid Disorder
• Sickle Cells Disease
• Maple Syrup Disease
• Critical Congenital Cardiac Disease
…

About Market Reports Center;
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.

Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
Email: info@marketreportscenter.com
Website: https://marketreportscenter.com

This release was published on openPR.